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Background: Scalp angiosarcoma is a rare soft tissue sarcoma with
a very poor prognosis and high mortality. Due to its low incidence,
prognostic factors and treatment strategies are not well deﬁned.
Objective: This study aims to report our long-term results in terms of
survival and prognostic factors affecting survival through retrospec-
tive analysis of 38 consecutive patients with scalp angiosarcomawho
underwent treatment at two different plastic centers in Hong Kong.
Result: The overall survival rate for 1, 3, and 5 years of maximally
treated patients was 56%, 24%, and 12%, respectively. Univariate
analysis with Cox regression model showed that age >70 years
(risk ratio, RR 5.0; p ¼ 0.02), satellite lesion on presentation (RR
8.4, p ¼ 0.02), and tumor of size >5 cm (RR 2.79, p ¼ 0.05) were
factors affecting the overall survival. Multivariate analysis showed
that only the involved deep resection margin was a signiﬁcant risk
factor (RR 8.6, p ¼ 0.02) However, univariate analysis showed that
the involved deep resection margin (RR 10.2, p ¼ 0.01) and satellite
lesion on presentation (RR 0.73, p ¼ 0.01) were factors affecting
disease-free survival. Besides, satellite lesion on presentation
predicted local recurrence on univariate analysis (RR 2, p ¼ 0.01).
Conclusions: The prognosis in terms of overall survival and local
disease control was poor with a 5-year survival rate of 12% in
maximally treated patients.
© 2015 The Authors. Published by Elsevier Ltd on behalf of British
Association of Plastic, Reconstructive and Aesthetic Surgeons. This
is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).. Pang).
er Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Cutaneous angiosarcoma is a rare, aggressive soft tissue sarcoma which mainly affects elderly
male.1e5 Angiosarcomas comprise approximately 2% of all soft tissue sarcomas, with 50% being cuta-
neous angiosarcomas.6 Cutaneous angiosarcomas involve the head and neck region with scalp being
the most commonly affected site. They constitute only 1% of all head and neck tumors.
Cutaneous angiosarcomas most often develop spontaneously. Nevertheless, few reports on ma-
lignant transformation from preexisting vascular lesions are available.6 They are believed to arise from
endothelial cells. Radiation is awell-known risk factor for breast angiosarcomas,7 but etiological factors
for cutaneous angiosarcomas remain unclear. They usually present as a bruise or a nodule that develops
into a diffuse plaque with satellite lesion rapidly.1
An early study in 1987 has shown that despite aggressive treatment, themedian survival was around
20monthswith a 5-year survival rate of 12%.1With the current developments in surgical techniques and
adjuvant treatment, recent studies have estimated the 5-year survival rate to be 22e43%.8e11 Patients
treated with radical radiotherapy alone had a 2-year inﬁeld control rate of 67% only.12
Treatment of scalp angiosarcoma is a multimodality approach including radical surgery, adjuvant
radiotherapy, chemotherapy, and immunotherapy. Studies show that due to the aggressive nature of
the disease, prognosis is generally poor, and complicated reconstructions are fraught with frequent
wound complications and delayed healing. Reasonable reconstruction options included skin graft on
calvarium after the removal of the outer cortex, local ﬂaps, and free ﬂaps.
In this study, we had retrospectively analyzed 38 consecutive patients with scalp angiosarcomawho
received treatment at two different plastic centers in Hong Kong. We report our long-term results in
terms of overall survival and prognostic factors affecting survival.
Patients and methods
All patients diagnosed with scalp angiosarcoma and treated at Queen Mary Hospital from 1987 to
2014 or Kwong Wah Hospital from 2003 to 2014 were included in this study. Data were obtained by
reviewing the medical records and electronic patient resources. A total of 42 consecutive patients were
identiﬁed, with two being excluded due to incomplete data. Two patients were lost to follow-up. The
remaining patients had either died or had up-to-date survival data and were still on follow-up at
regular intervals. The resultant median follow-up of all 38 patients was 11 months (range: 1 monthe12
years). Mortality was taken as the primary end point for determining overall survival. Local recurrence
or distant metastasis documented in clinical records and investigations was taken as the secondary end
point to determine disease-free survival.
These 38 patients with histologically conﬁrmed scalp angiosarcoma included 32 men (80%) and six
women (20%) with age range being 40e90 years (median ¼ 77 years). A single nodular lesion over the
scalp was observed in 45% of the patients (Figure 1), diffuse pattern lesion in 29%, and satellite lesion in
21% (Figure 2). The median duration between patients complaining of a scalp lesion and ﬁrst seeking
medical advice from primary care doctors was 6 weeks (range: 0 weekse2 years). Patients were
referred to us with a median delay of 6 weeks after their ﬁrst visit to primary care doctors (range:
0 weekse23months). Tumor size ranged from 2 to 20 cm (median: 9 cm); 26%were T1 tumors (5 cm)
and 68% T2 tumors (>5 cm). Three patients were diagnosedwithmetastatic regional lymphadenopathy
and two with systemic metastasis.
A total of 25 patients (66%) were treated with radical surgery, eight (21%) with palliative radio-
therapy to the scalp, and two (5%) with palliative chemoirradiation or immunotherapy, while three
patients (8%) refused treatment. In the case of the 25 patients who underwent wide local excision of
the scalp, the radial resection margins were 1e5 cm (median: 3 cm); craniectomy was performed in
ﬁve patients by neurosurgeons for deep margin control. Wide excision resulted in a scalp defect of
largest diameter (range: 7e30 cm, median: 16 cm). Six defects (24%) were reconstructed by skin
grafting, four (16%) by local ﬂaps, six (24%) by muscle-only free latissimus dorsi ﬂap along with skin
grafting, and six (24%) by free anterolateral thigh myocutaneous ﬂap (Figure 3). Seventy-six percent
patients received adjuvant radiotherapy to the scalp; four patients underwent chemotherapy, while
one underwent both chemotherapy and immunotherapy.
Figure 1. Scalp angiosarcoma presented as a single nodule (T1 tumor).
Figure 2. Scalp angiosarcoma presented as a satellite lesion.
Figure 3. Long-term results of a scalp defect following reconstruction of angiosarcoma resection with anterolateral thigh myocu-
taneous free ﬂap.
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a positive radial margin and ﬁve (20%) a positive deep margin.
Out of the 25 patients who received radical surgery as primary treatment, 64% had local recurrence,
38% nodal recurrence, and 67% systemic recurrence. During the study period, only three patients had
no disease recurrence, among whom one patient defaulted 2 months after treatment and another 6
months after treatment. During the study, one patient received adjuvant radiotherapy. Others had
deceased.
Statistics
Data were collected retrospectively and analyzed with SPSS v.17.0. (IBM, Armonk, NY, USA). Overall
survival, disease-free survival, and local disease-free survival were calculated with KaplaneMeier
survival curve. Univariate and non-conditional multivariate analysis of factors affecting survival was
analyzed with Cox regressionmodel. Statistical signiﬁcance result was deﬁned as p-value <0.05 on log-
rank test.
Results
The overall survival rates for 1, 3, and 5 years for patients who underwent radical surgery were 56%,
24%, and 12%, respectively. The 1-year survival rate for patients who received palliative radiotherapy or
chemotherapy or did not receive any treatment was 31% and there was no long-term survivor (deﬁned
as surviving beyond 3 years). The group treated with surgery had better survival outcome. (Pearson's
chi-square signiﬁcance, p ¼ 0.004).
The univariate analysis of overall survival in patients with scalp angiosarcoma treated with radical
surgery was performed with Cox regression model, and age >70 years (risk ratio, RR 5.0; p ¼ 0.02),
satellite lesion on presentation (RR 8.4, p ¼ 0.02) and T2 tumor (RR 2.79, p ¼ 0.05) were found to be
signiﬁcant risk factors affecting survival. Multivariate analysis showed that only the involved deep
resection margin was a signiﬁcant risk factor (RR 8.6, p ¼ 0.02). Other factors including sex, amount of
radial resection margin taken during surgery, craniectomy for deep margin control, and postoperative
adjuvant radiotherapy were not statistically signiﬁcant after calculation. The data are summarized in
Table 1.
The median disease-free survival was 7 months (1e32 months). Univariate analysis showed that
satellite lesion on presentation (RR 1.73, p ¼ 0.01) and the involved deep margin (RR 10.2, p ¼ 0.01)
were risk factors affecting disease-free survival. In addition, Cox regression univariate analysis showed
that satellite lesion on presentationwas also found to be a signiﬁcant risk factor for local recurrence (RR
2, p ¼ 0.01). Local recurrence was observed in 63% of the maximally treated patients.
Different methods of reconstruction in terms of skin grafting, local ﬂaps or free ﬂaps, had no impact
on survival outcome.
The 38 patients included three long-term survivors. All were initially treated with radical surgery
and adjuvant radiotherapy. Staging at diagnosis was T1N0M0 except for one patient with an unknown
primary tumor status. One patient died 5 years after treatment with local, nodal, and lung metastases,
one died 11 years after treatment with local recurrence only, and one died 12 years after treatment
with local, nodal, and brain metastases. At the time of this study, only 1 out of the 38 patients survived
while all others died from the disease.
Discussion
Our patients took a median of 6 weeks before seeking medical attention in primary care setting
when they ﬁrst complained of a scalp lesion. Majority of the patients initially thought this lesion to be a
bruise after minor injury; however, following the onset of symptoms, they attended the Emergency
Department or primary care clinics. Then, it took another 6 weeks (median) before referring to us from
primary care doctors for the suspicion of malignancy. It took 14 weeks (median) to arrive at the
diagnosis from when the patient was symptomatic. With the rapid growth rate of angiosarcoma, the
delay in diagnosis can result in more advanced local disease or systemic metastasis on presentation,
Table 1
Univariate and multivariate analysis with Cox regression model of potential factors affecting overall survival in patients with
scalp angiosarcoma treated with radical surgery.
Parameters Univariate analysis Multivariate analysis
Na HRa CIa p-Value HRa CIa p-Value
Sex Male 20 4.3 1.0e18.9 0.06 1.6 0.2e13.5 0.69
Female 2
Age >70 years old 18 5.0 1.4e18.2 0.02 1.4 0.3e1.0 0.66
70 years old 4
Morphology on presentation Nodular or diffuse pattern 19 8.4 1.4e52.6 0.02 0.0 0.0e>100 0.94
Satellite pattern 3
Gross resection margin <3 cm 10 1.2 0.5e2.9 0.74 1.2 0.4e3.7 0.77
3 cm 12
T staging T1 6 0.4 0.1e1.0 0.05 0.5 0.1e1.9 0.30
T2 16
N staging N0 21 0.72 0.1e5.6 0.75 0.2 0.1e2.8 0.23
N positive 1
Radial margin Clear 20 27.9 0.1e>100 0.26 >100 0.0e>100 0.93
Involved 2
Deep margin Clear 17 0.3 0.1e1.2 0.10 0.1 0.2e0.6 0.01
Involved 5
Adjuvant RT Yes 17 1.1 0.4e3.2 0.9 0.3 0.0e2.0 0.20
No 5
a N ¼ number of patients, HR ¼ hazard ratio, CI ¼ conﬁdence interval.
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series, the median duration between attending a primary care doctor and referring to us (plastic
surgeons) was 4 weeks in patients who eventually underwent radical surgery and 8 weeks in those
with palliative treatment alone. However, this observed difference did not affect survival signiﬁcantly,
possibly owing to the small sample size as well as recall bias of this retrospective study. Moreover, it
was observed that all long-term survivors (>5 years) with known tumor status on presentation had
T1N0M0 disease.
T2 tumors appear to have very poor overall survival. Early diagnosis and referral to surgeons
familiar with the disease may improve successful treatment rate and disease outcome. Our series only
had 26% of T1 tumors and an associated 5-year survival rate of only 12% with a median survival of 14
months. Compared to the literature, Pawlik13 similarly reported a series of 29 patients, with 24% being
T1 tumors and their observed 5-year survival rate was also 12%. Kohler et al (23 patients),9 Patel et al
(55 patients),11 and Guadagnolo et al (70 patients)10 reported improved 5-year survival rates of 21.7%,
38%, and 43%, respectively, in their studies, which involved 35%, 56%, and 82% of T1 tumors,
respectively.
All tumors presenting with satellite lesion in our study were T2 tumors. Apart from overall survival,
satellite lesion on presentation also predicted an increased local recurrence rate. By contrast, an
involved radial resection margin on parafﬁn section could predict neither local recurrence nor overall
survival. This could be due to the low incidence of involved radial margins. Only two patients were
reported to have involved radial margins after radical surgery. One patient defaulted follow-up and the
other died of local, nodal, and systemic recurrences 5 years after surgery. In our study, six patients
(24%) had involved radial or deep resection margins in our study, while 32e78.6% positive margins
were reported across studies.10,11,13 Although clear radial resection margin was not a signiﬁcant risk
factor affecting survival, involved deep resection margin was found to be a signiﬁcant risk factor
affecting overall survival on multivariate analysis and disease-free survival on univariate analysis. The
fact that involved deep resection margin was not found to be a signiﬁcant risk factor affecting the
overall survival on univariate analysis could be due to unbalanced sample size and interaction between
different categories.14 We advocated aggressive resection with a wide radial margin (median: 3 cm)
and craniectomy with free ﬂap reconstruction in cases of cranium invasion. Although evidence sug-
gests that radical surgery could possibly improve outcome, further studies are warranted to delineate
the optimal radial resection margin.
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ﬂaps,11 and tissue ﬂaps (with no speciﬁcation on free or local ﬂaps).13 In 48% of our patients, scalp
defects were reconstructed with free ﬂaps, among whom half underwent muscle-only free latissimus
dorsi ﬂap along with skin grafting and the other half free myocutaneous anterolateral thigh ﬂap. Scalp
defects following craniectomy for deep margin control could not be reconstructed with skin grafting
alone. But free ﬂaps allowed radical surgical resection and yielded a high rate of clear resection margin.
Some studies recommended simple reconstruction for quicker recovery and less morbidity as patients
were in their 70s and most often with multiple medical comorbidities.15 However in our experience,
most of our patients presented late with large scalp defect after surgical resection and a few patients
even required craniectomy for deep margin control, thereby rendering simple reconstruction not
feasible.
Thosewho had skin grafting alone experienced local symptoms including unstable graft andwound
problems during adjuvant radiotherapy. It is difﬁcult to distinguish wound complications from local
recurrences; hence, repeated biopsy is warranted in such cases. In this series, reconstruction with skin
grafting versus tissue ﬂaps appeared to have no effect on the overall survival and local disease control.
Despite being amoremajor undertaking, we advocate sophisticated free ﬂap reconstruction in selected
patients with acceptable operative risk for less wound complications during radiotherapy and better
cosmetic outcome.
Adjuvant radiotherapy and multimodality treatment were reported to be associated with an
improved outcome.8,10,11 This was not reﬂected in our data as only ﬁve patients were treated with
surgery alone with no radiotherapy, and there was insufﬁcient power to reach statistical signiﬁcance.
All our patients were referred to an oncologist for adjuvant radiotherapy after operation.
Although scalp angiosarcoma is a rare entity, our series of patients can be compared reasonably
with those reported. A few limitations have been identiﬁed. The sample size of this study was small,
and only a retrospective analysis was possible. Recall bias could not be avoided during data collection.
Face angiosarcomawas excluded in order to limit the heterogeneity of patients. As a future directive, a
systematic meta-analysis of case series or establishment of multicenter registries may provide further
insights into improving survivorship of this aggressive disease.
Conclusion
In this series, old age, T2 tumors, satellite lesion on presentation, and involved deep resection
margin were the signiﬁcant risk factors affecting the overall survival. Public and primary care
awareness on this severe disease is needed to reduce treatment delay. Radical surgery (sometimes in
the form of craniectomy) with free ﬂap reconstruction when necessary and adjuvant radiotherapy
remains to be the treatment of choice.
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